High-Dose Radioembolization Limited by Lung Shunt for Hepatocellular Carcinoma Supplied by the Inferior Phrenic Artery
🔍 **Clinical Question:**
Is radioembolization with lung-shunt limited high dose safe and effective via the inferior phrenic artery (IPA) supplying hepatocellular carcinoma (HCC)?
💡 **Key Insight:**
Radioembolization via the inferior phrenic artery was performed with acceptable toxicity in 43 of 44 patients with single nodular or oligonodular hepatocellular carcinoma of 4–12 cm in diameter.
The complete response rate and objective response rate by 1 session of radioembolization were 44.2% and 97.7%, respectively. The 2-year and 5-year overall survival rates were 83.9% and 70.9%, respectively.
👉 **Why it matters:**
Radioembolization with lung-shunt limited high dose can be performed with acceptable toxicity in patients with HCC supplied by the IPA.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.